View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Trump: Working On Lowering Cost Of Health Insurance
-
Piper Sandler: 'We Are Incrementally Positive on CVS, ALHC and UNH'
-
CVS Health (CVS) Says Some Pharmacies Impacted By Tech Glitches - Bloomberg
-
CVS Health subsidiary Omnicare files for Chapter 11 bankruptcy
-
Aetna to expand clinical collaboration program to ten hospitals by 2025
-
CVS Health (CVS) PT Raised to $85 at Wolfe Research
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.6% Yield
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Gilead stock falls after CVS holds off adding HIV prevention shot to plans
-
BMO Capital on Gilead Sciences (GILD): 'Expect GILD shares to be weaker on this announcement'
-
CVS Health (CVS) not yet adding Gilead's Yeztugo to its commercial or ACA plans - Reuters
-
Jefferies Reiterates Buy Rating on CVS Health (CVS)
-
UBS Upgrades CVS Health (CVS) to Buy
-
Baird Upgrades CVS Health (CVS) to Outperform
-
UnitedHealth Group (UNH), Humana (HUM), Others Climb
-
Truist: 'We Remain Bullish on CVS Health (CVS)'
-
CVS Health (CVS) Tops Q2 EPS by 35c, Beats on Revenue; Offers FY25 EPS Guidance
-
Analysts see stable EPS outlook for CVS ahead of Q2 results despite utilization headwinds
-
CVS Health (CVS) call put ratio 2 calls to 1 put into the expected release of quarter results
-
CVS Health (CVS) PT Lowered to $67 at UBS
-
15 names that Morgan Stanley’s analysts expect to move meaningfully on earnings
-
Humana stock falls after losing Medicare bonus payment lawsuit
-
Humana (HUM) Loses Medicare Bonus Payment Lawsuit - Bloomberg
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.9% Yield
-
TD Cowen on CVS Health (CVS): 'CNC's Pain Could Be CVS's Gain'
-
CVS Health (CVS) call put ratio 1.4 calls to 1 put
-
CVS Health (CVS) opens new WITC in Chicago
-
Cantor Fitzgerald Upgrades CVS Health (CVS) to Overweight
-
Medicare Pharmacy Benefit Manager Limits Stripped From Tax Bill - Bloomberg
-
Medicare Surfaces as Target for Cuts to Pay for Trump Tax Bill'- Bloomberg
-
Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Cantor Fitzgerald says CMS' new audit strategy has logistical challenges
-
Keybanc: 'CMS Expanding RADV Audits, MA Can't Catch a Break'
-
After-hours movers: Snowflake, Urban Outfitters, CVS Health
-
UnitedHealth (UNH), Others Lower as CMS Will Expand Audits Of Medicare Advantage Plans
-
Takeaways from UBS's 2025 Healthcare Insurance Symposium
-
CVS Health (CVS) call put ratio 1 call to 2.6 puts as share price down 1.2%
-
Bernstein: 'We See the Reaction to PBM Stocks as Off Target'
-
CVS Health (CVS), Others Fall After Trump Said Will Cut out Middle Man on Drugs
-
CVS Health (CVS) PT Raised to $86 at JPMorgan
-
Glenview Capital Issues Statement on CVS Health (CVS)
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Novo Nordisk shares jump as FDA accepts oral Wegovy application
-
CVS Health (CVS) Evercore Removes Two Names from TAP Outperform List
-
CVS Health (CVS) Tops Q1 EPS by 61c; raises guidance
-
CVS Health (CVS) call put ratio 4 calls to 1 put with a focus on May 2 weekly 67 calls
-
CVS Health (CVS) May 2 weekly 65 straddle priced into quarter results
-
Truist Securities Reiterates Buy Rating on CVS Health (CVS) Amid CFO Transition

